Research ArticleBehavioral Pharmacology
Apparent CB1 receptor rimonabant affinity estimates: combination with THC and synthetic cannabinoids in the mouse in vivo triad model
Travis W Grim, Anthony J Morales, Brian F Thomas, Jenny L Wiley, Gregory W Endres, Sidney S Negus and Aron H Lichtman
Journal of Pharmacology and Experimental Therapeutics April 25, 2017, jpet.117.240192; DOI: https://doi.org/10.1124/jpet.117.240192
Travis W Grim
1 Virginia Commonwealth University;
Anthony J Morales
1 Virginia Commonwealth University;
Brian F Thomas
2 Research Triangle Institute;
Jenny L Wiley
2 Research Triangle Institute;
Gregory W Endres
3 Cayman Chemical
Sidney S Negus
1 Virginia Commonwealth University;
Aron H Lichtman
1 Virginia Commonwealth University;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleBehavioral Pharmacology
Apparent CB1 receptor rimonabant affinity estimates: combination with THC and synthetic cannabinoids in the mouse in vivo triad model
Travis W Grim, Anthony J Morales, Brian F Thomas, Jenny L Wiley, Gregory W Endres, Sidney S Negus and Aron H Lichtman
Journal of Pharmacology and Experimental Therapeutics April 25, 2017, jpet.117.240192; DOI: https://doi.org/10.1124/jpet.117.240192
Research ArticleBehavioral Pharmacology
Apparent CB1 receptor rimonabant affinity estimates: combination with THC and synthetic cannabinoids in the mouse in vivo triad model
Travis W Grim, Anthony J Morales, Brian F Thomas, Jenny L Wiley, Gregory W Endres, Sidney S Negus and Aron H Lichtman
Journal of Pharmacology and Experimental Therapeutics April 25, 2017, jpet.117.240192; DOI: https://doi.org/10.1124/jpet.117.240192
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement